Posts in the “Treatment Options Treatment Options” category:

Detecting and Treating ALK-Positive Lung Cancers

Posted by Samantha Powell on August 26th, 2014 |

Hello. This is Mark Kris, from Memorial Sloan Kettering Cancer Center in New York City. I want to spend a few minutes talking about the treatment of ALK-positive lung cancers and ROS1, another of the oncogene fusion-driven lung cancers. We have had some recent data come out. I think the first piece to discuss is […]

Do you really need that medical test or treatment?

Posted by Samantha Powell on August 4th, 2014 |

For some time there has been a nationwide effort to cut back on unnecessary medical tests, over-prescribed drugs and surgery that doesn’t end up helping people feel better. But old habits die hard. Dr. Emma Trejo knows that only too well. As an internist practicing in the South Bay city of Lawndale, she says patients […]

Bristol-Myers Squibb and Ono Pharmaceutical Co., Ltd. Announce Strategic Immuno-Oncology Collaboration in Japan, South Korea and Taiwan

Posted by Samantha Powell on July 23rd, 2014 |

Bristol-Myers Squibb Company (NYSE:BMY) and Ono Pharmaceutical Co., Ltd. (“Ono”) have signed a strategic collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea and Taiwan. As part of the agreement, Bristol-Myers Squibb and Ono […]

New Cancer Care Payment Model Reduced Health Care Costs, Maintained Outcomes

Posted by Samantha Powell on July 8th, 2014 |

A new cancer care payment model that rewards physicians for focusing on best treatment practices and health outcomes rather than the number of drugs they prescribe resulted in significant cost savings without affecting the quality of care. The three-year study, conducted by UnitedHealthcare and five medical oncology groups around the country, covered 810 patients with […]

GEOFFREY OXNARD: How Do I Treat Patients with Lung Cancer Harboring EGFR T790M?

Posted by Samantha Powell on July 5th, 2014 |

T790M is a point mutation in the EGFR gene that is associated with resistance to epidermal growth factor receptor (EGFR) kinase inhibitors like erlotinib and gefitinib. Some of the most exciting results presented at this year’s American Society of Clinical Oncology Annual Meeting have to do with new inhibitors targeting the EGFR T790M mutation. Given […]

Baptist Health System Creates the South Texas Lung Institute, the Region’s First Dedicated Lung Disease Treatment Program

Posted by Samantha Powell on July 4th, 2014 |

Lung cancer is responsible for more cancer-related deaths in both men and women in the United States than the next three most common cancers combined (colon, breast and pancreatic). According to the American Cancer Society, almost 220,000 people are diagnosed with lung cancer each year, with tobacco use being a major risk factor in the […]

Gibbs Cancer Center selected to test new drugs for lung cancer

Posted by Samantha Powell on July 2nd, 2014 |

The Gibbs Cancer Center and Research Institute in Spartanburg has been selected as one of the first 10 sites in the world to test new drugs that target the type of lung cancer often associated with smoking. Patients who meet eligibility requirements will be administered the drugs based on a 200-gene profile, which uses biomarkers […]

If You’re HIV-Positive, You’re Less Likely to Get Cancer Treatment

Posted by Samantha Powell on July 1st, 2014 |

Scientists have long recognized that cancer patients with HIV infections have lower survival rates than cancer patients without the virus. A Journal of Clinical Oncology paper published online today might offer new insight into this phenomenon: Researchers at the University of Pennsylvania found that HIV patients with several early-stage cancers are between some two and […]

Fasting for three days renews entire immune system, protects cancer patients, ‘remarkable’ new study finds

Posted by Samantha Powell on June 5th, 2014 |

Fasting for three days can regenerate the entire immune system, even in the elderly, scientists have found in a breakthrough described as “remarkable.” Although fasting diets have been criticized by nutritionists, research suggests that starving the body kick-starts stem cells into producing more white blood cells, which fight off infection. Scientists at the University of […]

Clovis Lung Cancer Treatment Received FDA Breakthrough Therapy Status

Posted by Samantha Powell on May 19th, 2014 |

Date: 5/19/14 Outlet Full Name: The Denver Post Author: Anna Prior Clovis Oncology Inc. said its lung-cancer treatment received breakthrough therapy status from the Food and Drug Administration, sending shares 6 percent higher to $56.77 in after-hours trading. The company is currently developing CO-1686, a drug for the treatment of non-small cell lung cancer […]